What is KOR Whitening?
KOR Whitening operates at the intersection of advanced chemical engineering and clinical dentistry. The company is widely recognized for its proprietary Dual-Activated, Tri-Barrel Hydremide Peroxide formulation, a technology that addresses even the most stubborn dental discolorations, such as tetracycline staining. By mandating a cold-chain logistics process—ensuring continuous refrigeration from manufacturing to the dental chair—KOR maintains a distinct competitive advantage in product potency. Unlike consumer-grade alternatives that rely on light or laser activation, KOR focuses on high-efficacy, professional-only delivery systems that prioritize patient outcomes and long-term enamel health. This specialized approach has established the brand as a preferred partner for dental practitioners seeking reliable, high-performance whitening protocols.
How much funding has KOR Whitening raised?
KOR Whitening has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in KOR Whitening
PPP
Public-Private Partnership
What's next for KOR Whitening?
The infusion of capital signals a transition toward aggressive market expansion and potential R&D acceleration. As the company navigates this late-stage growth phase, the focus will likely shift toward increasing its footprint within global dental networks and optimizing its supply chain for the specialized, temperature-sensitive product line. By leveraging this recent financing, KOR Whitening is poised to further differentiate its clinical offerings, potentially exploring new delivery modalities or expanding its reach into emerging international markets where demand for premium aesthetic dentistry is rising. The strategic deployment of these funds will be critical in maintaining the company's reputation for clinical excellence while scaling its operational infrastructure to meet the evolving needs of dental professionals worldwide.
See full KOR Whitening company page
